ArticleBreast cancer research and treatment2025

Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation.

Chenxing Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.